OVERVIEW

From Detection to Treatment: Advancing the Fight Against Nontuberculous Mycobacterial Lung Disease is organized by Healio, Medical Learning Institute, LLC.

CE Activity Release Date: June 24, 2025
CE Activity Expiration Date: June 23, 2026

Description:
Be part of an engaging dialogue, previously presented and recorded at the ATS 2025 International Conference, where leading pulmonology and infectious disease experts will provide cutting-edge insights into Nontuberculous Mycobacterial Lung Disease (NTM-LD).

This interactive session will help you:

  • Enhance your clinical skills in diagnosing and managing NTM-LD
  • Understand the latest strategies for differentiating NTM species and optimizing treatment plans
  • Explore real-world patient cases and learn practical approaches for managing recurrent infections

Learning Objectives:
After completing this CE activity, the participant should be better able to:

  • Assess the incidence and prevalence of NTM-LD
  • Identify patients at risk of NTM-LD, including when to use standard diagnostic methods such as radiological and microbiological analysis
  • Select from current and emerging treatment options for NTM-LD, including those for recurrent infections, based on clinical evidence and to enhance patient quality of life
Credits

Credits:
In support of improving patient care, Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education:
Medical Learning Institute Inc (MLI) designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Statement:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participation information will be shared through the ACCME's Program and Activity Reporting System (PARS).

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Continuing Certification Statement:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Thoracic Surgery’s Maintenance of Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABTS credit.

Participation information will be shared through the ACCME's Program and Activity Reporting System (PARS).

For Physicians requesting ABIM MOC or ABTS CC credit, the post-test and evaluation are required in their entirety as well as your ABIM or ABTS ID number, DOB (MM/DD), and a score of 70% or higher is needed to obtain MOC/CC credit.

ECMEC:
The European Union of Medical Specialists-European Accreditation Council for Continuing Medical Education (UEMS-EACCME®) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 Credit(s)™. into European CME credit (ECMEC®) should contact the UEMS (www.uems.eu).

PA:
Medical Learning Institute Inc has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until June 23, 2026. PAs should only claim credit commensurate with the extent of their participation.

Nursing Continuing Professional Development:
Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hour and 0.35 contact hour in the area of pharmacology.

Pharmacy:
Medical Learning Institute Inc designates this application-based continuing education activity for 1.0 contact hour (0.1 CEU) of the Accreditation Council for Pharmacy Education.

Interprofessional Continuing Education (IPCE) Statement:
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

  • 1 CME
  • 1 AAPA
  • 1 MOC
  • 1 AMA PRA Category 1 Credit™
  • 1 Contact Hours
  • 0.1 CEU
  • 1 IPCE
  • TARGET AUDIENCE

    PhysicianPharmacistPhysician AssistantHealthcare ProfessionalsNursesInfectious Diseases PhysicianPulmonologistsNurse Practitioners

    SPECIALITIES

    PulmonologyInfectious Disease

    RELATED ONLINE COURSES

    Webcast

    Emergency Medicine
    More actions
    US$200

    Webcast

    Pediatrics
    28 AMA PRA Category 1 Credits™
    More actions
    US$910